TrialJournal for immunotherapy of cancer2026

Induction toripalimab plus chemotherapy sequential concurrent chemoradiotherapy with nimotuzumab followed by toripalimab maintenance in stage IVB hypopharyngeal squamous cell carcinoma: a single-arm phase 2 study.

Zeyang Geng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.